SCHEMBL30324809

SCHEMBL30324809

CS(=O)(=O)OCC1CCC(OCc2ccccc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 2/20 0.45
OPRL1 P41146 2/20 0.45
SIGMAR1 Q99720 2/20 0.43
CARM1 Q86X55 2/20 0.43
PRMT6 Q96LA8 2/20 0.43
TMEM97 Q5BJF2 1/20 0.43
PRMT8 Q9NR22 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
DPP4 P27487 1/20 0.42
EPHX2 P34913 1/20 0.39
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CTSK P43235 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
HCRTR2 O43614 3/20 0.39
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
GRIN1 Q05586 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL583025 0.87 FFAR1 (0.43) OPRM1OPRL1SIGMAR1CARM1PRMT6
SCHEMBL16398438 0.85 CTSL (0.45) CTSLCTSBCTSKCA1CA2
SCHEMBL16398437 0.85 CTSL (0.45) CTSLCTSBCTSKCA1CA2
SCHEMBL5518662 0.83 BCHE (0.42) OPRM1OPRL1SIGMAR1CARM1PRMT6
SCHEMBL5518667 0.83 BCHE (0.42) OPRM1OPRL1SIGMAR1CARM1PRMT6
SCHEMBL717952 0.82 OPRM1 (0.49) OPRM1OPRL1SIGMAR1CARM1PRMT6
SCHEMBL5523451 0.80 PKM (0.37) CARM1PRMT6HCRTR2
SCHEMBL5523447 0.80 PKM (0.37) CARM1PRMT6HCRTR2
SCHEMBL25360969 0.78 OPRM1 (0.46) OPRM1OPRL1SIGMAR1CARM1PRMT6
SCHEMBL6469380 0.78 OPRM1 (0.59) OPRM1OPRL1SIGMAR1CARM1PRMT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240390298-A1 CYCLOHEXYL BETA-HYDROXY ALKYL AMINES AND MEDICAL USES THEREOF ATROGI AB (SE) 2024-11-28 US disclosed
EP-4405041-A1 CYCLOHEXYL BETA-HYDROXY ALKYL AMINES AND MEDICAL USES THEREOF Atrogi AB (SE) 2024-07-31 EP disclosed
WO-2023046882-A1 CYCLOHEXYL BETA-HYDROXY ALKYL AMINES AND MEDICAL USES THEREOF ATROGI AB (SE) 2023-03-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240390298-A1 CYCLOHEXYL BETA-HYDROXY ALKYL AMINES AND MEDICAL USES THEREOF H1-5, CYP3A5, HRH3 OPRM1 53/4885OPRL1 264/4885SIGMAR1 97/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.